GL1X · GenesisL1 explorer

MolNFT v1 · #118223 · protein

Crystal structure of the metallo-beta-lactamase L1 in complex with the bisthiazolidine inhibitor D-VC26

5EVD: “Crystal structure of the metallo-beta-lactamase L1 in complex with the bisthiazolidine inhibitor D-VC26”. X-ray diffraction, 3 ligands (VC2, ZN, SO4), 2 pockets (best druggability 0.44). MolNFT v1 #118223 on GenesisL1: 3D structure…

PDB
5EVD
Type
protein
Length
267 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Metallo-beta-lactamase L1
EC
3.5.2.6
UniProt
P52700
Ligands
VC2, ZN, SO4
Pockets
2 · best druggability 0.44

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMetallo-beta-lactamase L1 (EC 3.5.2.6)protein26731% helix, 24% strandP52700

Ligands and binding sites

  • VC2 · (3S,5S,7aR)-2,2-dimethyl-5-(sulfanylmethyl)tetrahydro[1,3]thiazolo[4,3-b][1,3]thiazole-3-carboxylic acid · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11370.440.7628VC2, ZN
2630.310.7521SO4

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 5EVD · Crystal structure of the metallo-beta-lactamase L1 in complex with the bisthiazolidine… · the same entry in another collection · chain A against A, TM-score 1.00
  • P52700 · AlphaFold monomer V2.0 prediction for metallo-beta-lactamase L1 type 3 (P52700) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.